Lazard Asset Management’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06M | Buy |
29,293
+44
| +0.2% | +$4.59K | ﹤0.01% | 873 |
|
|
2025
Q1 | $3.41M | Sell |
29,249
-508,420
| -95% | -$59.3M | 0.01% | 805 |
|
|
2024
Q4 | $45.5M | Buy |
537,669
+451,737
| +526% | +$38.2M | 0.07% | 208 |
|
|
2024
Q3 | $7.72M | Buy |
+85,932
| New | +$7.72M | 0.01% | 524 |
|